Skip to main content
. 2009 Jan 7;37(4):1202–1210. doi: 10.1093/nar/gkn1040

Table 1.

Effects of aminoacylation with phenylalanine and anticodon substitution on koff (min−1 × 103) from the ribosomal A site

tRNA GAA anticodon
GAC anticodon
Deacyl- Phe- Deacyl- Phe-
tRNA2Ala >500a 9.1 (2.3) 30 (±6)a 4.4 (0.4)b
tRNA2Arg 38 (5) 6.7 (1.6) 4.5 (0.8) 7.0 (1.6)
tRNA2Glu 120 (39) 5.1 (1.9) 4.4 (1.6) 3.7 (1.0)
tRNA3Gly 27 (8) 5.6 (1.7) 3.0 (0.7) 4.9 (1.2)
tRNA1Ile 57 (18) 7.3 (1.3) 6.8 (2.3) 4.8 (1.7)
tRNALys 65 (11) 4.5 (1.1) 3.6 (1.0) 3.2 (0.6)
tRNAMet 73 (17) 7.4 (1.1) 5.2 (1.8) 6.0 (1.5)
tRNAPhe 110 (39) 8.4 (1.2) 4.1 (1.1) 4.2 (0.3)b
tRNA3Thr 68 (23) 4.8 (1.1) 3.3 (1.0) 5.2 (0.4)b
tRNATrp 13 (5) 4.4 (1.4) 4.3 (1.9) 4.9 (1.7)
tRNA2Tyr 37 (8) 7.0 (1.8) 4.5 (1.7) 5.2 (2.1)
tRNA2AVal 76 (31) 8.5 (4.0) 6.3 (1.9) 5.1 (0.8)b

All koff values were measured with complementary codons. Values (±SD) are for at least three separate experiments. 0.5 min−1 is upper limit of the assay.

aOlejniczak et al. (3).

bDale and Uhlenbeck (8).

HHS Vulnerability Disclosure